Ben Askew

Ben Askew Email and Phone Number

President Breakthrough Chemistry Advisors
Ben Askew's Location
Wilmington, North Carolina, United States, United States
Ben Askew's Contact Details

Ben Askew personal email

n/a
About Ben Askew

A highly regarded drug hunter with over 30 years of pharmaceutical and biotechnology industries experience and a proven track record of delivering high quality clinical candidates across various therapeutic areas including: Oncology; Cardiovascular; Bone Metabolism,; Diabetes and Endocrinology; Fertility; Autoimmunity and Inflammation; and CNS and Neurodegeneration. Extensive experience in project and portfolio management, including portfolio and resource allocation following mergers and acquisitions. Demonstrated strong leadership abilities in large and mid-sized pharmaceutical and biotech settings; including management of multinational organizations and project teams as well as effective collaborations with CROsSpecialties: Building high functioning Medicinal chemistry organization, design of selective kinase inhibitors, development drugs against GPCRs, nuclear receptors, integrin antagonists, protease inhibitors, evaluation of in-licensing opportunities, managing external resources,.

Ben Askew's Current Company Details

President Breakthrough Chemistry Advisors
Ben Askew Work Experience Details
  • Surf Bio
    Board Member
    Surf Bio Apr 2022 - May 2024
  • Avenge Bio
    Board Member
    Avenge Bio Jan 2022 - May 2024
    Natick, Massachusetts, Us
  • Sermonix Pharmaceuticals Llc
    Board Member
    Sermonix Pharmaceuticals Llc Nov 2021 - May 2024
    Columbus, Ohio, Us
  • A-Alpha Bio
    Board Member
    A-Alpha Bio Sep 2021 - May 2024
    Seattle, Washington, Us
  • Perceptive Advisors
    Partner
    Perceptive Advisors May 2021 - May 2024
  • Asclepix Therapeutics, Inc.
    Board Member
    Asclepix Therapeutics, Inc. Jun 2020 - May 2024
    Baltimore, Maryland, Us
  • Zucara Therapeutics Inc.
    Board Observer
    Zucara Therapeutics Inc. May 2020 - May 2024
    Vancouver, Bc British Columbia, Ca
  • Xontogeny
    Partner, R&D
    Xontogeny Sep 2019 - May 2024
    Boston, Ma, Us
  • Breakthrough Chemistry Advisors, Llc
    President
    Breakthrough Chemistry Advisors, Llc Aug 2012 - Sep 2019
    Proprietor of a drug discovery consulting firm offering a variety of services to clients in Pharmaceutical, Biotechnology and Venture Capital firms and academic research institutions.
  • Scifluor Life Sciences, Llc
    Vice President, Research
    Scifluor Life Sciences, Llc Jan 2013 - Dec 2018
    Oversee the development and expansion of the company’s pipeline of Fluoropeutics™ – a proprietary portfolio of new chemical entities (NCEs) consisting of fluorinated versions of small molecule drugs with substantial human clinical or post-marketing experience.
  • Blueprint Medicines
    Scientific Advisory Board Member
    Blueprint Medicines Mar 2012 - Mar 2013
    Cambridge, Massachusetts, Us
  • Third Rock Ventures
    Entrepreneure-In-Residence
    Third Rock Ventures Aug 2011 - Jul 2012
    Boston, Ma, Us
  • Emd Serono
    Vp Research, Global Head Of Nce Technologies
    Emd Serono Sep 2009 - Jul 2011
    Boston, Massachusetts, Us
  • Merck Serono Since 2008
    Global Head Of Medicinal Chemistry
    Merck Serono Since 2008 2008 - Sep 2010
    Darmstadt, Hessen, De
  • Serono
    Director Of Chemistry
    Serono 2005 - 2006
    Boston, Massachusetts, Us
    Led chemistry team that developed 3 Ind candidates in 2 years .
  • Amgen
    Director Of Chemistry
    Amgen 2000 - 2005
    Thousand Oaks, Ca, Us
  • Merck
    Sr Research Fellow
    Merck May 1990 - Aug 2000
  • At&T Bell Labs
    Member Of Technical Staff
    At&T Bell Labs 1988 - 1990
    Designed molecular probes for optical imaging in living neurons .

Ben Askew Skills

Oncology Kinases Drug Discovery Drug Development Medicinal Chemistry Biotechnology Drug Metabolism Lifesciences Nuclear Receptors Pharmaceutical Industry Intellectual Property Business Intelligence Antibody Drug Conjugates Cro Gpcrs Immunology Biopharmaceuticals Assay Development Cell Culture Hplc Small Molecules Cell Biology Drug Design Biochemistry Technology Transfer Inflammation Clinical Development Business Strategy Biomarkers Molecular Biology Portfolio Management Chemistry Diabetes Pharmacology Protein Chemistry Pharmaceutics High Throughput Screening Cancer Antibodies Translational Medicine Purification In Vitro Cross Functional Team Leadership Leadership Lead Change Ind Life Sciences

Ben Askew Education Details

  • University Of Pittsburgh
    University Of Pittsburgh
    Organic Chemistry
  • Gannon University
    Gannon University
    Chemistry/Biology

Frequently Asked Questions about Ben Askew

What is Ben Askew's role at the current company?

Ben Askew's current role is President Breakthrough Chemistry Advisors.

What is Ben Askew's email address?

Ben Askew's email address is be****@****uor.com

What is Ben Askew's direct phone number?

Ben Askew's direct phone number is +161768*****

What schools did Ben Askew attend?

Ben Askew attended University Of Pittsburgh, Gannon University.

What are some of Ben Askew's interests?

Ben Askew has interest in Children, Civil Rights And Social Action, Education, Science And Technology, Human Rights.

What skills is Ben Askew known for?

Ben Askew has skills like Oncology, Kinases, Drug Discovery, Drug Development, Medicinal Chemistry, Biotechnology, Drug Metabolism, Lifesciences, Nuclear Receptors, Pharmaceutical Industry, Intellectual Property, Business Intelligence.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.